Ronald Nixon

Provides medical products, advanced biotechnology solutions and applications

Catalyst Group invests in middle market companies located in the United States with an enterprise value of USD 10 – 100 million. The fund focuses on healthcare services, medtech, infrastructure, hospitality and consumer services sectors. It participates in acquisitions, MBOs, recapitalizations and growth stage capital transactions with an investment size of USD 2 - 20 million. It acquires minority, majority and controlling interest.

Provides home health and hospice care services

Provides directional drilling services

Catalyst/Hall seeks investment opportunities in middle market companies located in the United States, primarily on Southwest and Midwest Regions with revenue of $10 million to $100 million. The fund focuses on companies operating in the fields of manufacturing, distribution, and services. It provides financing for mezzanine, buyout, MBO and growth stage capital requirement with an investment size of $1 million to $5 million for mezzanine and $2 million to $10 million for equity.

Functions as a College/University

Operates resort and luxury hotels

Provides differentiated completion services for blue chip oil and gas operators

Nixon Capital uses a long-only value strategy to invest in equity securities of public companies for SMAs, while utilizes a long/short, opportunistic value strategy to invest in equity, debt, and derivative securities around the globe for the Fund. The firm employs a fundamental analytical approach to security analysis, continually conducting quantitative and qualitative analysis.